Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat

Rosario Samanin, Caterina Bendotti, Gianluigi Candelaresi, Silvio Garattini

Research output: Contribution to journalArticlepeer-review

Abstract

The effect of quipazine on brain monoamines and the significance of this interaction in its anorectic activity was studied in rats. At doses ranging from 2.5 to 10 mg/kg quipazine markedly reduced brain 5-hydroxyindolacetic acid concentrations without significant effects on steady-state levels of serotonin, noradrenaline and dopamine. Striatal levels of homovanillic acid were significantly reduced by 10 mg/kg of quipazine but not modified by a dose of 5 mg/kg. Quipazine counteracted the decrease of brain serotonin induced by fenfluramine but did not significantly modify the effect of 6-hydroxydopamine on brain nonadrenaline and dopamine. The decrease of food intake induced by 5 mg/kg of quipazine was completely prevented by pretreatment with methergoline but was not affected by an intraventricular injection of 6-hydroxydopamine or pretreatment with penfluridol, propranolol or phentolamine. The results indicate that at doses between 2.5 and 5 mg/kg quipazine specifically acts on brain serotonin and this interaction may be important for its anorectic activity.

Original languageEnglish
Pages (from-to)1259-1265
Number of pages7
JournalLife Sciences
Volume21
Issue number9
DOIs
Publication statusPublished - Nov 1 1977

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat'. Together they form a unique fingerprint.

Cite this